NanoViricides Inc (NNVC)

US · Healthcare · Biotechnology

$1.40+16.67%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-2.0M

EPS

$-0.09

EPS estimate

$-0.08

EPS came in at -0.09 against a street estimate of -0.08 — a miss of 12.5%.

Market cap

$26.0M

Forward P/E

0.0

P/B

2.84

Book value

$0.42

EPS (TTM)

$-0.44

52-week high

$2.23

52-week low

$0.85

50-day MA

$1.41

200-day MA

$1.26

Beta

1.66

Analysts rate NanoViricides Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.00.

Insiders

2.35%

Institutions

9.29%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NanoViricides Inc — free to start.

Data updated 2026-09-18.